Hikma Pharmaceuticals

-4.0%

Hikma Pharmaceuticals is a global pharmaceutical company headquartered in London, United Kingdom. It was founded in 1978 in Amman, Jordan and has since expanded its operations to over 50 countries, with a strong presence in the Middle East, North Africa, and the United States.
Hikma is a leading company in generic and branded pharmaceuticals, serving patients in a wide range of therapeutic areas including respiratory, oncology, infectious diseases, and cardiovascular diseases. The company also has a portfolio of over 1000 branded products, including over-the-counter medications, Hikma-branded generics, and specialty, injectable, and biosimilar products.
Hikma is committed to providing affordable and high-quality medications to people around the world. The company's mission is to help people live better and healthier lives by providing essential medicines and healthcare products.
Hikma has a strong focus on research and development, investing a significant portion of its revenue into developing new products and improving existing ones. The company also works closely with healthcare professionals and patients to understand their needs and develop innovative solutions.
Hikma is also dedicated to sustainability and ethical business practices. The company has implemented numerous initiatives to reduce its environmental impact and ensure responsible sourcing and manufacturing processes.
Overall, Hikma Pharmaceuticals is a well-respected and established global pharmaceutical company with a strong commitment to improving global health and access to affordable medicines.

1. Rich History and Experience: Hikma Pharmaceuticals has been in operation for over 40 years and has grown into a leading global pharmaceutical company with a proven track record of success.
2. Diversified Product Portfolio: The company offers a diverse range of branded and generic medicines, as well as injectable and respiratory products.
3. Strong Global Presence: Hikma has a strong global presence, with operations in over 50 countries and a presence in emerging markets, making it one of the most geographically diversified pharmaceutical companies.
4. Focus on High-Quality and Affordable Medicines: Hikma is committed to providing high-quality, affordable medicines to improve patients' lives and meet their healthcare needs.
5. Key Partnerships and Collaborations: Hikma has established strong partnerships with global pharmaceutical companies, healthcare organizations, and local governments to expand its reach and deliver its products to more patients worldwide.
6. Emphasis on Research and Development: The company invests heavily in research and development to discover and develop new medicines and improve existing ones.
7. Strong Financial Performance: Hikma has a solid financial track record with consistent revenue and profitability growth, demonstrating its ability to navigate market challenges and deliver strong returns to shareholders.
8. Sound Corporate Social Responsibility (CSR) Practices: The company is committed to making a positive impact on society through various CSR initiatives, including promoting access to healthcare, supporting education and environmental sustainability.
9. Award-Winning Company: Hikma has received several awards and recognition for its operations, products, and corporate practices, including being named one of the most ethical companies in the world by the Ethisphere Institute.
10. Culture of Innovation and Excellence: Hikma has established a culture of innovation and excellence that drives its success and allows it to adapt to changing market dynamics and meet the evolving healthcare needs of patients.

The business model of Hikma Pharmaceuticals is based on the development, manufacturing, and marketing of a wide range of generic, branded, and in-licensed pharmaceutical products. The company operates primarily in the MENA region, the United States, and Europe, focusing on providing affordable and high-quality medicines to patients in these markets.
Hikma's business model is divided into three main segments:
1. Branded Pharmaceuticals: This segment includes the research, development, and marketing of innovative branded medicines. Hikma's branded portfolio focuses on therapeutic areas such as oncology, cardiovascular, respiratory, and neurology, among others.
2. Generic Pharmaceuticals: This segment includes the development, manufacture, and distribution of high-quality generic drugs. Hikma offers a broad portfolio of generic products in various therapeutic areas, including oncology, cardiovascular, and central nervous system.
3. Injectables: Hikma is one of the world's largest manufacturers of generic injectable drugs. It specializes in complex, sterile injectable products, including oncology, critical care, and anti-infectives.
In addition to these segments, Hikma also has a strong focus on research and development, with ongoing investment in new product development and enhancing its existing product portfolio. The company also leverages strategic partnerships and collaborations to expand its product offering and geographical presence.
Overall, Hikma's business model is driven by its commitment to providing high-quality, affordable medicines to patients, supported by a robust research and development pipeline and a global presence.

1. Hikma Pharmaceuticals was founded in 1978 in Amman, Jordan by Samih Darwazah, who remains the Honorary Chairman of the company.
2. The name Hikma (also spelled Hakimah) is an Arabic word meaning wisdom or knowledge.
3. Hikma Pharmaceuticals started as a small family business, with just 16 employees and a single product.
4. The company expanded rapidly, and by 1996, it had become the largest pharmaceutical manufacturer in the Middle East and North Africa.
5. In 1996, Hikma opened its first international production facility in Portugal, followed by facilities in Italy and the United States.
6. In 2005, Hikma Pharmaceuticals became the first Middle Eastern company to be listed on the London Stock Exchange.
7. Hikma has a strong focus on research and development, with over 800 scientists and researchers working in their R&D centers around the world.
8. The company has a portfolio of over 800 products, ranging from branded generics to branded and specialized products.
9. Hikma is the largest pharmaceutical company in the MENA region, with operations in over 50 countries.
10. The company has a strong commitment to sustainability and has been recognized for its efforts in reducing its environmental impact and promoting social responsibility.
See Company Due Diligence: